L

Legend Biotech Corp
D

LEGN

34.230
USD
-1.78
(-4.94%)
Post Trading·34.500USD+0.270(+0.79%)
حجم التداول
144,208
الربح لكل سهم
0
العائد الربحي
-
P/E
-25
حجم السوق
6,357,873,080
المقالات
المزيد

العنوان: Legend Biotech Corp

القطاع: Healthcare
الصناعة: Biotechnology
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.